N
HAE icon

Numerai’s Haemonetics HAE Stock Holding History

Numerai’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,883
Closed -$290K – 601
2025
Q2 		$290K Sell
3,883
-3,208
-45% -$212K 0.04% 379
2025
Q1 		$451K Buy
7,091
+1,123
+19% +$76.4K 0.09% 302
2024
Q4 		$466K Sell
5,968
-9,111
-60% -$732K 0.13% 231
2024
Q3 		$1.21M Buy
15,079
+11,277
+297% +$911K 0.32% 101
2024
Q2 		$315K Buy
+3,802
New +$334K 0.11% 236

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Numerai's HAE Position: Q3 2025 in Review

Numerai sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 3,883 shares — an estimated $290K sold.

Numerai first reported a position in HAE in Q2 2024 and held it in 5 quarters. The position peaked at $1.21M in Q3 2024. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Numerai reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • Numerai sold 3,883 Haemonetics shares in Q3 2025, an estimated $290K.
  • Numerai first reported a position in Haemonetics in Q2 2024 and held it in 5 quarters.
  • Numerai's Haemonetics position peaked at $1.21M in Q3 2024.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Numerai's 13F filing for Q3 2025, filed 14 Nov 2025.